Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ITM1 Inhibitors

ITM1 Inhibitors, associated with the gene STT3A, encompass a range of compounds that can either directly or indirectly inhibit the function of the protein encoded by STT3A. This protein, STT3A, is a critical subunit of the oligosaccharyltransferase complex, pivotal in N-linked glycosylation, a fundamental process in protein maturation and function. These inhibitors are of significant interest in research, particularly in the study of protein biosynthesis and post-translational modifications. STT3A plays a vital role in the process of N-linked glycosylation, where oligosaccharides are attached to specific nitrogen atoms on asparagine residues in proteins. This modification is crucial for proper protein folding, stability, and function. The inhibition of STT3A, and thus the disruption of N-linked glycosylation, can provide critical insights into the role of glycosylation in protein biology.

Direct inhibitors of STT3A would interact with the protein in a manner that impedes its enzymatic activity in glycosylation. These inhibitors could bind to the active site of STT3A or to allosteric sites, altering the protein's conformation and thereby reducing its ability to participate in the glycosylation process. The study of direct inhibitors can reveal essential aspects of the enzyme's structure-function relationships and its role in protein maturation. Indirect inhibitors, conversely, do not target STT3A directly but affect the pathways and processes it is involved in. These compounds might influence upstream signaling pathways or cellular processes that regulate the activity or expression of STT3A. For example, compounds that disrupt the function of the endoplasmic reticulum or Golgi apparatus can indirectly impact the N-linked glycosylation process. Similarly, molecules that affect the cellular localization or stability of STT3A would also modulate its activity. In research settings, ITM1 Inhibitors are valuable for studying the complex processes of protein folding and stability. By inhibiting STT3A, scientists can explore the consequences of impaired glycosylation on protein structure and function. This research can lead to a deeper understanding of various cellular processes, including protein trafficking, cell signaling, and immune response, as glycosylation plays a crucial role in all these areas.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$172.00
$305.00
66
(3)

Inhibits N-linked glycosylation, potentially affecting STT3A's role in protein processing.

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$138.00
$251.00
$631.00
$815.00
$1832.00
6
(1)

Inhibits glycosylation processing enzymes, potentially impacting pathways involving STT3A.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$135.00
$540.00
$1025.00
$6248.00
25
(2)

Mannosidase I inhibitor, potentially affecting glycosylation processes involving STT3A.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$73.00
$145.00
(0)

Inhibits glycosidase, which could affect glycosylation processes where STT3A is involved.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$184.00
$632.00
10
(1)

Inhibitor of glucosidases, potentially impacting STT3A-involved glycosylation pathways.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, which may indirectly affect protein processing pathways involving STT3A.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor, can affect protein degradation pathways that may interact with STT3A.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Lysosomal inhibitor, potentially affecting degradation pathways involving glycosylated proteins.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Inhibits V-ATPase, affecting lysosomal function, potentially impacting STT3A-related pathways.